Insider Transactions in Q1 2024 at Puma Biotechnology, Inc. (PBYI)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2024
|
Alan H Auerbach President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,577
+0.09%
|
-
|
|
Feb 12
2024
|
Jeffrey Jerome Ludwig Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,067
+17.56%
|
-
|
|
Feb 12
2024
|
Maximo F Nougues Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,307
+20.12%
|
-
|
|
Feb 12
2024
|
Alvin F Wong Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,307
+23.47%
|
-
|
|
Feb 12
2024
|
Alan H Auerbach President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
160,796
+2.22%
|
-
|
|
Feb 12
2024
|
Douglas M Hunt Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,894
+21.16%
|
-
|
|
Jan 03
2024
|
Jeffrey Jerome Ludwig Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
12,956
-11.47%
|
$51,824
$4.49 P/Share
|
|
Jan 03
2024
|
Alvin F Wong Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,733
-7.3%
|
$30,932
$4.49 P/Share
|
|
Jan 03
2024
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
41,396
-0.59%
|
$165,584
$4.49 P/Share
|
|
Jan 03
2024
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,682
-10.86%
|
$62,728
$4.49 P/Share
|
|
Jan 03
2024
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
8,358
-7.48%
|
$33,432
$4.49 P/Share
|